The objective is that the INPI (National Institute of Industrial Property) does not grant the patent registry to an American laboratory for an essential remedy in the treatment of the disease.

It is unplugged from existing health and science & technology policies. South Africa recently adopted a new Intellectual Property Policy, which seeks to align IP with the country’s national development plan.

An article on the accessibsa project’s work in The Hindu (Tamil edition)

A recently published report “Pharmaceutical Patent Grants in India: How our safeguards against evergreening have failed and why the system must be reformed“, by Dr. Feroz Ali, Dr. Sudarsan Rajagopal, Dr. Venkata S. Raman and Roshan John…

On 1 April 2013, in a packed room inside India’s Supreme Court, a magnificent building in Indo-British architectural style, two judges delivered a verdict that impacted the national and global conversation about patents and patients.